07 May 2025
07 May 2025
The test operates on Roche's cobas analysers and requires one assay, delivering outcomes in 18 minutes.
The BrightHeart platform enables clinicians to view real-time analysis of foetal congenital heart defects directly on a cart-side tablet.
In 2024, InBrain completed the world’s first human application of a graphene-based BCI at a UK hospital.
The company plans to commercialise the device immediately across the country.
A Texas court has struck down the FDA’s Final Rule to regulate LDTs in the same way as medical devices. But is that the end of the story?
The new feature is the result of a $75m partnership between the two companies, announced in late 2024.
Though designed as economic tools, tariffs have ripple effects that extend into the regulatory framework of the medical device sector.
It assessed around 200 subjects and over 2,100 plasma samples across various distinct subtypes.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
